lncRNA NEAT1通过miR-454-3p/SLC2A1/GLUT1分子轴调控Warburg效应进而调控分化型甲状腺癌碘抵抗的机制研究
批准号:
81960322
项目类别:
地区科学基金项目
资助金额:
32.0 万元
负责人:
刘超
依托单位:
学科分类:
核医学诊断与治疗
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
刘超
中文摘要
分化型甲状腺癌(DTC)是全球常见的内分泌恶性肿瘤之一,Warburg效应作为肿瘤细胞能量代谢的重要特征,与放疗抵抗密切相关,但Warburg效应调控机制尚未阐明。前期研究发现,Lnc NEAT1在放射性碘抵抗DTC细胞中高表达,荧光素酶实验证实Lnc NEAT1与miR-454-3p互作进而调控下游靶基因SLC2A1。SLC2A1及其编码的葡萄糖单向转运蛋白(GLUT1),已经证明与Warburg效应密切相关。我们推测:过表达Lnc NEAT1通过下调miR-454-3p及上调SLC2A1/ GLUT1,导致Warburg效应。项目进一步研究Lnc NEAT1调控Warburg效应影响放射性抵抗发生的机制。通过检测131I敏感以及131I抵抗患者的血液样本中的Lnc NEAT1、miR-454-3p、SLC2A1及GLUT1表达,找出两组患者的差异性。为临床治疗DTC放射抵抗提供新方案。
英文摘要
Differentiated thyroid carcinoma(DTC) is one of the most common endocrine malignancies in the world. Warburg effect, as an important feature of energy metabolism of tumor cells, not only promotes the proliferation and invasion of tumor cells, but also is closely related to the resistance to chemotherapy and radiotherapy. However, the regulatory mechanism of Warburg effect remains unclear. Previous studies have shown that Inc NEAT1 is highly expressed in radioactive iodine-resistant PTC cells, and the luciferase test confirmed that Inc NEAT1 will interact with miR-454-3p to regulate the downstream target gene SLC2A1.SLC2A1 and the key protein of glucose one-way transport (GLUT1) encoded by SLC2A1 have been proved to be closely related to the Warburg effect. We hypothesize that the overexpression of Inc NEAT1 will result in Warburg effect by down-regulating miR-454-3p and up-regulating SLC2A1/ GLUT1. We will further explore the mechanisms Inc NEAT1’s regulation on Warburg effect on the occurrence of radioactive resistance. The expression levels of Inc NEAT1, miR-454-3p, SLC2A1 and GLUT1 in blood samples of patients in 131I-sensitive group and 131I- resistant group will be tested, and the differences between the two groups will be explored. As a result, it will provide a new clinical treatment of DTC radiation resistance.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
登录
查看更多内容
DOI:
--
发表时间:
2021
期刊:
中国医药科学
影响因子:
作者:
[王昀, 刀钰洋, 李浩宇, 侯飞, 刘超]
通讯作者:
刘超
Antimicrobial power of biosynthesized Ag nanoparticles using refined Ginkgo biloba leaf extracts
使用精制银杏叶提取物生物合成银纳米颗粒的抗菌能力
DOI:
10.1007/s11706-022-0594-8
发表时间:
2022-05
期刊:
Frontiers of Materials Science
影响因子:
2.7
作者:
[Wenbo Zhuang, Dafeng Hu, Xudong Zhang, Kai Xiong, Xiao Ding, Jian Lu, Yong Mao, Peng Yang, Chao Liu, Yanfen Wan]
通讯作者:
Yanfen Wan
Relationship between long non-coding RNA PCAT-1 expression and gefitinib resistance in non-small-cell lung cancer cells.
非小细胞肺癌细胞长链非编码RNA PCAT-1表达与吉非替尼耐药的关系
DOI:
10.1186/s12931-021-01719-7
发表时间:
2021-05-12
期刊:
Respiratory research
影响因子:
5.8
作者:
[Wang S, Liu C, Lei Q, Wu Z, Miao X, Zhu D, Yang X, Li N, Tang M, Chen Y, Wang W]
通讯作者:
Wang W
DOI:
--
发表时间:
2023
期刊:
Journal of Cancer Research and Clinical Oncology
影响因子:
作者:
[Fei Hou, Ting Chen, Chang‑Long Yang, Xiao‑Dan Sun, Zhi‑Xian Yang, Juan Lv, Chao Liu, Zhi-yong Deng]
通讯作者:
Zhi-yong Deng
DOI:
10.3724/abbs.2021013
发表时间:
2022-01-25
期刊:
Acta biochimica et biophysica Sinica
影响因子:
3.7
作者:
[Liu C, Wang Y, Dao Y, Wang S, Hou F, Yang Z, Liu P, Lv J, Lv L, Li G, Zhou Y, Deng Z]
通讯作者:
Deng Z
共 9 条
125I粒子阻断ZNF479突变介导的CENPM/mTOR调控mtOXPHOS在宣威家族性肺癌精准治疗中的应用研究
-
批准号:82560353
-
项目类别:地区科学基金项目
-
资助金额:32.00万元
-
批准年份:2025
-
负责人:刘超
-
依托单位:
国内基金
海外基金